Merck & Co., Inc. (MRK) Stock Overview
Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.
Merck & Co., Inc. (MRK)
Key Financials
Key Financials
Market Cap
368.5B
P/E Ratio
119.76
EPS (TTM)
$3.21
ROE
0.07%
MRK Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Merck & Co., Inc. (NYSE: MRK) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Merck & Co., Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MRK on the NYSE shows an RSI of 76.38, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $148.17 for the NYSE listing.
Key metrics behind Merck & Co., Inc.'s NYSE-traded stock include a P/E ratio of 119.76 and a market capitalization of 368.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MRK on the NYSE.